Economic Burden of Medically Attended Respiratory Syncytial Virus Infections Among Privately Insured Children Under 5 Years of Age in the USA.

ABSTRACT:

Background

The cost of medically attended RSV LRI (lower respiratory infection) is critical in determining the economic value of new RSV immunoprophylaxes. However, most studies have focused on intermittent RSV encounters, not the episode of care that captures the entirety of RSV illness.

Methods

We created age- and condition-specific cohorts of children under 5 years of age using MarketScan® data (2015-2019). We contrasted aggregating healthcare costs over RSV-LRTI episodes to ascertaining costs based on RSV-specific encounters only. Economic burden was estimated by multiplying costs per encounter or per episode by their respective incidence rates.

Results

Average cost was higher per episode than per encounter regardless of settings (inpatient: $28,586 vs. $18,056 an

SUBMITTER: Tran PT 

PROVIDER: S-EPMC11216811 | biostudies-literature | 2024 Jul

REPOSITORIES: biostudies-literature